Pınar ANĞIN, Ali Doğukan ANĞIN, İsmet GÜN, Yasemin ALAN, Gökhan GÜLYAŞAR, Onder SAKİN, Resul KARAKUŞ, Süleyman ESERDAĞ, Vildan ELİBOL, Aldulmecit ÖKTEM

Vajinal enfeksiyon varlığı ve tipinin kadında cinsel yaşama etkisi

AMAÇ: Vajinal akıntıya neden olan enfeksiyon ajanına göre kadın cinsel fonksiyonlarını değerlendirmeyi amaçladık. Bizim bildiğimiz kadarıyla, en sık görülen üç farklı ajanın kadın cinsel fonksiyonları üzerine etkisini değerlendiren ilk prospektif çalışmadır.GEREÇ ve YÖNTEMLER: Prospektif non-randomize çalışmamızda va-jinal akıntı şikâyetiyle başvuran 230 hastadan pap-smear alındı. Pap-smear sonucu normal veya inflamasyon olarak raporlanan hastalar kont-rol grubunu (Grup 1, n: 122) oluştururken trikomonas (Grup 2, n: 27), bakteriyel vajinozis (BV) (Grup 3, n: 40) ve kandidiyazis olarak raporla-nan hastalar (Grup 4, n: 41) çalışma grubunu oluşturdu. Toplam skorun ≤26,55 olması kadın seksüel disfonksiyonu (FSD) olarak kabul edildi.BULGULAR: Gruplar total FSFI ve subgruplar olan istek, uyarılma, ıslanma, orgazm, tatmin, ağrı skorları açısından ve toplam FSD hasta sayıları açısından karşılaştırıldığında istatiksel olarak anlamlı bir fark saptanmadı (p>0,05). Koku, renkli akıntı (beyaz, sarı, yeşil) ve kaşıntı tarifleyen hasta sayısı Grup 1’de istatiksel anlamlı olarak yüksek tespit edildi (p

The effect of vaginal infection and type on women’s sexual life

OBJECTIVE: We aimed to evaluate female sexual function according to the infective agent causing a vaginal discharge. To the best of our knowledge, this is the first study to evaluate the effects of 3 different agents on female sexual function.MATERIAL and METHODS: In this prospective, nonrandomized study, a pap-smear was taken from 230 patients who presented with complaints of vaginal discharge. The patients were separated into groups according to the pap-smear results. Patients that presented as normal or with inflammation formed the control group (Group 1, n: 122), and study groups were formed of those presenting with trichomonas (Group 2, n: 27), bacterial vaginosis (Group 3, n: 40) and candidiasis (Group 4, n: 41). Patients with a total score of ≤26.55 were classified as having a female sexual dysfunction.RESULTS: No statistically significant difference was determined between the groups with respect to total female sexual function index scores and the subdimensions of desire, arousal, wetness, orgasm, satisfaction and pain, and the total number of female sexual dysfunction patients (p>0.05). The number of patients with odorous, colored discharge (white, yellow, green) and itching was significantly higher in Group 1 than in the other groups (p

PDF

___

1.de Paula Von Glehn M, Sidon LU, Machado ER. Gynecological complaints and their associated factors among women in a family health-care clinic. J Fam Med Prim Care 2017;6:88–92. [CrossRef ]
2.Paladine HL, Desai UA. Vaginitis: Diagnosis and Treatment. Am Fam Physician 2018;97:321–9. https://www.aafp.org/afp/2018/0301/p321.html
3.JR Berman. Physiology of female sexual function and dysfunction. Int J Impot Res 2005;17:S44–51. [CrossRef ]
4.Hainer LB, Gibson MV. Vaginitis: Diagnosis and Treatment. Am Fam Physician 2011;83:807–15. https://www.aafp.org/afp/2011/0401/p807.html
5.Van Lankveld J, Granot M, Weijmar Schultz W, Binik YM, Wesselmann U, Pukall CF, et al. Women’s sexual pain disorders. J Sex Med 2010;7:615–31. [CrossRef ]
6.Subramanian C, Nyirjesy P, Sobel JD. Genital malodor in women: a modern reappraisal. J Low Genit Tract Dis 2012;16:49–55. [CrossRef ]
7.Heim LJ. Evaluation and Differential Diagnosis of Dyspareunia. Am Fam Physician 2001;63:1535–44. https://www.aafp.org/afp/2001/0415/p1535.html
8.Hodges AL, Holland AC. Common Sexually Transmitted Infections in Women. Nurs Clin North Am 2018;53:189–202. [CrossRef ]
9.Dina Khnaba, Rostom S, Lahlou R, Bahiri R, Abouqal R, Hajjaj-Hassouni N. Sexual dysfunction and its determinants in Moroccan women with rheumatoid arthritis. Pan African Med J 2016;24:1–13. [CrossRef ]
10.Rabiepoor S, Khalkhali HR, Sadeghi E. Whatkind of sexual dysfunction is most common among overweight and obese women in reproductive age? Int J Impot Res 2017;29:61–4. [CrossRef ]
11.Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191–208. [CrossRef ]
12.Öksüz E, Malhan S. The Reliability and Validity of Turkish Version of Female Sexual Function Index. Sendrom 2005;17:54–60. https://www.researchgate.net/publication/285879607_Reliability_and_validity_of_the_Female_Sexual_Function_Index_in_Turkish_population
13.Hart G. Factors associated with trichomoniasis, candidiasis and bacterial vaginosis. Int J SRN AIDS 1993:4:21–5. [CrossRef ]
14.Loo SK, Tang WY, Lo KK. Clinical significance of Trichomonas vaginalis detected in Papanicolaou smear: a survey in female Social Hygiene Clinic. Hong Kong Med J 2009;15:90–3. https://www.hkmj.org/abstracts/v15n2/90.htm
15.Tokyol C, Aktepe OC, Cevrioğlu AS, Altindiş M, Dilek FH. Bacterial vaginosis: comparison of Papsmear and microbiological test results. Mod Pathol 2004;17:857–60. [CrossRef ]
16.Audisio T, Pigini T, de Riutort SV, Schindler L, Ozan M, Tocalli C, Bertolotto P. Validity of the Papanicolaou Smear in the Diagnosis of Candida spp., Trichomonas vaginalis, and bacterial Vaginosis. J Low Genit Tract Dis 2001;5:223–5. [CrossRef ]
17.Wiese W, Patel SR, Patel SC, Ohl CA, Estrada CA. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000;108:301–8. [CrossRef ]
18.Kucukdurmaz F, Inanc Yı, Inanc Yu, Resim S. Sexual dysfunction and distress in premenopausal women with migraine: association with depression, anxiety and migraine-related disability. Int J Impot Res 2018;30:265–71. [CrossRef ]
19.Carranza-Lira S, Núńez F. Sexual dysfunction prevalence in a group of pre- and postmenopausal Mexican women. Menopause Review/Przeglad Menopauzalny 2018;17:39–42. [CrossRef ]
20.Ege E, Akın B, Arslan SY, Bilgili N. Prevalence and risk factors of female sexual dysfunction among healthy women. TUBAV 2010;3:137–44. https://dergipark.org.tr/tr/download/article-file/200874
21.Aslan E, Beji NK, Gungor I, Kadioglu A, Dikencik BK. Prevalence and risk factors for low sexual function in women: a study of 1009 women in an out patient clinic of a university hospital in Istanbul. J Sex Med 2008;5:2044–52. [CrossRef ]
22.Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. Theprevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int 2004;72:52–7. [CrossRef ]
23.Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 2006;175:654–8. [CrossRef ]
24.Higgins JA, Hoffman S, Graham CA, Sanders SA. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from theWomen’sWell-Being and Sexuality Study. Sex Health 2008;5:321–30. [CrossRef ]
25.Burrows LJ, Basha M, Goldstein AT. Theeffects of hormonalcontraceptives on femalesexuality: A review. J Sex Med 2012;9:2213–23. [CrossRef ]
26.Higgins JA, Hirsch JS. The pleasure deficit: revisiting the “sexuality connection” in reproductive health. Perspect Sex Reprod Health 2007;39:240–7. [CrossRef ]
27.Randolph ME, Pinkerton SD, Bogart LM, Heather Cecil H, Abramson PR. Sexual Pleasure and Condom Use. Arch Sex Behav 2007;36:844–8. [CrossRef ]
28.Erbil N. Prevalence and Risk Factors for Female Sexual Dysfunction Among Turkish Women Attending a Maternity and Gynecology Outpatient Clinic. Sex Disabil 2011;29:377–86. [CrossRef ]
29.Fajewonyomi BA, Orji EO, Adeyemo AO. Sexual dysfunction among female patients of reproductive age in a hospital setting in Nigeria. J Health Popul Nutr 2007;25:101–6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013270/
30.Sidi H, Puteh SE, Abdullah N, Midin M. The prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women. J Sex Med 2007;4:311–21. [CrossRef ]
31.Singh JC, Tharyan P, Kekre NS, Singh G, Gopalakrishnan G. Prevalence and risk factors for female sexual dysfunction in women attending a medical clinic in South India. J Postgrad Med 2009;5:113–20. [CrossRef ]
32.Gordon D, Gardella C, Eschanbach D, Mitchell MC. High prevalence of sexual dysfunction in a vulvovaginal specialty clinic. Low Genit Tract Dis 2016;20:80–4. [CrossRef ]
33.Gungor AN, Uludag A, Sahin M, Gencer M, Uysal A. Gungor AN, et al. Effects of vaginal discharge on female sexual function. Int J Gynaecol Obstet 2014;124:27–9. [CrossRef ]
34.Giraldo PC, Polpeta NC, Juliato CRT, Yoshida LP, Gomes do Amaral RL, Eleutério J Jr. Evaluation of sexualfunction in Brazilian women with recurrent vulvovaginal candidiasis and localized provoked vulvodynia. J Sex Med 2012;9:805–11. [CrossRef ]
35.Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004;291:1368–79. [CrossRef ]
36.Doty RL, Ford M, Preti G, Huggins GR. Changes in the intensity and pleasantness of human vaginal odors during the menstrual cycle. Science 1975;190:1316–8. [CrossRef ]
37.Akarsu RH, Beji NK. Kadın cinsel fonksiyon bozuklukları sınıflandırılmasında DSM-V kapsamında yapılan değişiklikler. Androloji Bülteni 2016;18:133–7. [CrossRef ]
38.Wright JJ, O’Connor KM. Female Sexual Dysfunction. Med Clin North Am 2015;99:607–28. [CrossRef ]
39.Wiese W, Patel SR, Patel SC, Ohl CA, Estrada CA. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 2000;108:301–8. [CrossRef ]
40.Karakuş R, İsmailov H, Namazov A, Arınkan SA, Temizkan O, Anğın AD, Karakuş SS. Research of the efficacy of topical local anesthesia for hysteroscopy: a randomised-controlled trial Med Bull Sisli Etfal Hosp 2014;48:86–91. [CrossRef ]
41.Aşıcıoğlu O, Temizkan O, Arıcı B, Aşıcıoğlu BB. Clinical Characteristics and Outcomes of Laparoscopic Surgery in Ovarian Endometrioma Cases Treated at a Gynecology Clinic. Med Bull Sisli Etfal Hosp 2018;52:1–5. [CrossRef ]
42.Carrillo-Meléndrez H, Villamil-Cerda D, Espinoza-Hernández J, Lacy-Niebla RM. Vulvar pruritus: determination of the most common causes and their treatments. Ginecol Obstet Mex 2015;83:179–88. https://pubmed.ncbi.nlm.nih.gov/26058171/